Skip to content
Search

Latest Stories

Submit Guest Post

UK injects over £40 million into vaccine projects set for human trials

THE UK government has announced a £20-million funding for a Oxford University project on a Covid-19 vaccine, which is set for human trials from Thursday, and £22.5 million for Imperial College London to support its clinical trials.

Health Secretary Matt Hancock told the daily Downing Street briefing on Tuesday (21) that the health department was “throwing everything” at trying to find a vaccine because it is a critical aspect of the Covid-19 pandemic fight and lifting the strict lockdown measures in place to curb its spread.


"Both of these promising projects are making rapid progress, and I have told the scientists leading them that we will do everything in our power to support," he said, adding that it normally "would take years to get to this point."

"The UK is at the forefront of the global effort – we've put in more money than any other into the global search for a vaccine. Nothing about this is inevitable. Vaccine production is a matter of trial and error. But the UK will throw everything it has at trying to find one."

The announcement came as UK had another major daily leap in the hospital death toll from coronavirus, up by 823 to hit 17,337 by Tuesday.

Hancock said the government's plan to control the rapid spread of the virus and prevent the NHS from being overwhelmed was working as the rate of hospitalisations with Covid-19 was showing a downward trajectory.

He also maintained that the problems over PPE shortage were being addressed by actively engaging with thousands of companies, including 159 manufacturers in the UK.

“We are determined to get people the PPE they need. This is a 24/7 operation, one of the biggest cross-government operation I have ever seen," said Hancock.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Migrants pay 60% more into NHS than their healthcare costs, analysis finds

The Immigration Health Surcharge is a fee that most people applying for eligible UK visas must pay as part of their immigration application. It is intended to contribute towards the cost of healthcare during their stay in the country.

Migrants pay 60% more into NHS than their healthcare costs, analysis finds

Highlights:

  • Migrants paying the IHS contributed at least 60% more to NHS finances than their estimated healthcare costs in 2023/24, including standard tax contributions.
  • The annual surcharge has risen from £200 to £1,035 for most visa applicants.
  • IHS revenue peaked at almost £2.5 billion in 2024/25.
  • The surcharge now accounts for more than 1 per cent of the NHS budget.
  • Revenue fell to £2.3 billion in 2025/26 as immigration numbers declined.
  • Around one-fifth of the NHS workforce comes from overseas, according to the Nuffield Trust fellow quoted in the report.

  • Migrants who pay to live and work in the UK are contributing substantially more to NHS finances than the estimated cost of the healthcare they receive, according to new analysis by the Nuffield Trust. The findings have reignited debate over immigration, healthcare funding and the purpose of the Immigration Health Surcharge (IHS).

    Keep ReadingShow less